1-17 of 17
Nirav N. Shah
Close
Sort by
Journal Articles

Outpatient Administration of CAR T-cell Therapies Using a Strategy of No Remote Monitoring and Early CRS Intervention

Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S. Fenske, Faiqa Farrukh, Walter Longo, Othman Salim Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N. Shah, Mehdi Hamadani
Journal: Blood Advances
Blood Adv bloodadvances.2024013239.
https://doi.org/10.1182/bloodadvances.2024013239
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy

Clinical Trials & Observations
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Tamara K. Moyo, Vaishalee Kenkre, Thomas A. Ollila, Lindsey Fitzgerald, Brian Hess, Kevin David, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S. Bhansali, Elyse I. Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2592–2599.
https://doi.org/10.1182/bloodadvances.2023011996
Published: 2024
Journal Articles

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin David, Megan M. Herr, Oluwatobi Odetola, Adam Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Ishan Roy, Deborah Stephens, Alexey Danilov, Nirav N. Shah, Stefan K. Barta, Matthew Cortese, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2327–2331.
https://doi.org/10.1182/bloodadvances.2024012573
Published: 2024
Journal Articles

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Clinical Trials & Observations
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S. Fenske, Nirav N. Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M. Evens, Barbara Pro
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1612–1620.
https://doi.org/10.1182/bloodadvances.2023011369
Published: 2024
Includes: Supplemental data
Journal Articles

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

Jackson T. Bowers, Jacob Anna, Steven M. Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A. Spinner, Shuning Li, Marcus R. Messmer, Joseph Nguyen, Emily C. Ayers, Charlotte B. Wagner, Boyu Hu, Mengyang Di, Scott F. Huntington, Fateeha Furqan, Nirav N. Shah, Christina Chen, Hatcher J. Ballard, Mitchell E. Hughes, Elise A. Chong, Sunita D. Nasta, Stefan K. Barta, Daniel J. Landsburg, Jakub Svoboda
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6630–6638.
https://doi.org/10.1182/bloodadvances.2023010622
Published: 2023
Includes: Supplemental data
Journal Articles

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

Clinical Trials & Observations
Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B. Cohen, Tamara K. Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason Romancik, Rahul S. Bhansali, Elyse I. Harris, Mckenzie Sorrell, Rebecca Masel, Adam S. Kittai, Nathan Denlinger, Audrey M. Sigmund, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane Winter, Barbara Pro, Leo I. Gordon, Alexey Danilov, Deborah Stephens, Nirav N. Shah, Vaishalee Kenkre, Stefan K. Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2657–2669.
https://doi.org/10.1182/bloodadvances.2022008240
Published: 2023
Includes: Supplemental data
Journal Articles

Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy

Fateeha Furqan, Morgan Maring, Aniko Szabo, Timothy S. Fenske, Mehdi Hamadani, Nirav N. Shah
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2463–2467.
https://doi.org/10.1182/bloodadvances.2022009025
Published: 2023
Includes: Supplemental data
Journal Articles

CAR T-cell therapy for secondary CNS DLBCL

Gulrayz Ahmed, Mehdi Hamadani, Nirav N. Shah
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5626–5630.
https://doi.org/10.1182/bloodadvances.2021005292
Published: 2021
Includes: Supplemental data
Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Clinical Trials & Observations
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3180–3190.
https://doi.org/10.1182/bloodadvances.2019001266
Published: 2020
Includes: Supplemental data
Journal Articles

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Clinical Trials & Observations
Nirav N. Shah, Bryon D. Johnson, Timothy S. Fenske, Renju V. Raj, Parameswaran Hari
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2119–2122.
https://doi.org/10.1182/bloodadvances.2020001626
Published: 2020
Journal Articles

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Clinical Trials & Observations
Talha Badar, Narendranath Epperla, Aniko Szabo, Steven Borson, John Vaughn, Gemlyn George, Neeraj Saini, Abdul Rashid Shah, Romil D. Patel, Sairah Ahmed, Nirav N. Shah, Amanda F. Cashen, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2020) 4 (1): 47–54.
https://doi.org/10.1182/bloodadvances.2019000736
Published: 2020
Journal Articles

Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Yi-Bin Chen, Nirav N. Shah, Anne S. Renteria, Corey Cutler, Johan Jansson, Mona Akbari, Chunlin Chen, Syed Quadri, Andrejus Parfionovas, Steven M. Devine
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4136–4146.
https://doi.org/10.1182/bloodadvances.2019000893
Published: 2019
Includes: Supplemental data
Journal Articles

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Scott R. Solomon, Andrew St. Martin, Nirav N. Shah, Giancarlo Fatobene, Monzr M. Al Malki, Karen K. Ballen, Asad Bashey, Nelli Bejanyan, Javier Bolaños Meade, Claudio G. Brunstein, Zachariah DeFilipp, Richard E. Champlin, Ephraim J. Fuchs, Mehdi Hamadani, Peiman Hematti, Christopher G. Kanakry, Joseph P. McGuirk, Ian K. McNiece, Stefan O. Ciurea, Marcelo C. Pasquini, Vanderson Rocha, Rizwan Romee, Sagar S. Patel, Sumithira Vasu, Edmund K. Waller, John R. Wingard, Mei-Jie Zhang, Mary Eapen
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2836–2844.
https://doi.org/10.1182/bloodadvances.2019000627
Published: 2019
Journal Articles

Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation

Clinical Trials & Observations
Narendranath Epperla, Talha Badar, Aniko Szabo, John Vaughn, Steve Borson, Neeraj Y. Saini, Romil D. Patel, Nirav N. Shah, Mehdi Hamadani, Sairah Ahmed, Amanda F. Cashen, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1661–1669.
https://doi.org/10.1182/bloodadvances.2019000102
Published: 2019
Includes: Supplemental data
Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Clinical Trials & Observations
Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, Arun K. Singavi, Maryam Sarraf Yazdy, Nirav N. Shah, John N. Allan, Erica B. Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J. Schuster, AnnaLynn M. Williams, Alan P. Skarbnik, Andre H. Goy, Julie M. Goodfriend, Colleen Dorsey, Catherine C. Coombs, Hande Tuncer, Chaitra S. Ujjani, Ryan Jacobs, Allison M. Winter, John M. Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew Zelenetz, Amy A. Kirkwood, Christopher P. Fox
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1568–1573.
https://doi.org/10.1182/bloodadvances.2019000180
Published: 2019
Journal Articles

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks, Wael Saber
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2922–2936.
https://doi.org/10.1182/bloodadvances.2018024844
Published: 2018
Includes: Supplemental data
Journal Articles

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Clinical Trials & Observations
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D’Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2018) 2 (8): 933–940.
https://doi.org/10.1182/bloodadvances.2018018531
Published: 2018
Includes: Supplemental data